T1	Participants 36 78	adolescents with autism spectrum disorders
T2	Participants 313 352	children with autism spectrum disorders
T3	Participants 521 664	higher functioning adolescents with autism spectrum disorders and comorbid anxiety disorders enrolled in a randomized controlled trial (n = 30)
